Spasmodic dysphonia: introductory phonetic analyses

被引:3
|
作者
Reid, Eric W. [1 ]
Nobriga, Christina, V [1 ]
机构
[1] Loma Linda Univ, Sch Allied Hlth, Commun Sci & Disorders Dept, Loma Linda, CA 92350 USA
关键词
Adductor spasmodic dysphonia; syllable stress; content word; phonetic context; voicing; RECURRENT LARYNGEAL NERVE; BOTULINUM TOXIN; ACOUSTIC FEATURES; PERCEPTION; STRESS; EXPERIENCE;
D O I
10.1080/02699206.2022.2096483
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Adductor spasmodic dysphonia (ADSD) is a neurological dystonia characterised by involuntary adductor spasms of the larynx during speech. Spasm frequency is often reported to increase during syllables that begin with voiced speech sounds, especially glottal stops. Because of its underlying physical and acoustic complexities, the voicing contrast in American English (AE) appears unlikely to interact consistently with a singular physical phenomenon like laryngeal spasm. This retrospective study investigated additional phonetic contrasts and their relationship to spasm frequency. Standardised, 144-word recordings of 36 participants with adductor spasmodic dysphonia were analysed. Productions were coded for rater-perceived syllable stress, voiced/voiceless onset, vowel/consonant onset, and word-onset place and manner of production. Phonetic contexts were compared using independent sample t-tests and Kruskal-Wallis statistics. Contexts in which spasm varied significantly included stressed/unstressed syllables, content/function words, and multisyllabic/monosyllabic words. Study results reaffirm the clinical usefulness of standardised ADSD/ABSD sentences during differential diagnosis but conflict with previous studies that report a connection between ADSD spasm and phoneme voicing.
引用
收藏
页码:883 / 898
页数:16
相关论文
共 50 条
  • [31] Striatal dopaminergic function in spasmodic dysphonia
    Simonyan, K.
    Herscovitch, P.
    MOVEMENT DISORDERS, 2009, 24 : S111 - S112
  • [32] BOTULINUM TOXIN TREATMENT FOR SPASMODIC DYSPHONIA
    KOBAYASHI, T
    NIIMI, S
    KUMADA, M
    KOSAKI, H
    HIROSE, H
    ACTA OTO-LARYNGOLOGICA, 1993, : 155 - 157
  • [33] Botulinum toxin for the treatment of spasmodic dysphonia
    Gibbs, SR
    Blitzer, A
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2000, 33 (04) : 879 - +
  • [34] Disfluency in spasmodic dysphonia: A multivariate analysis
    Cannito, MP
    Burch, AR
    Watts, C
    Rappold, PW
    Hood, SB
    Sherrard, K
    JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH, 1997, 40 (03): : 627 - 641
  • [35] Anxiety and depression in spasmodic dysphonia patients
    Amanda Hu
    Al Hillel
    Wei Zhao
    Tanya Meyer
    世界耳鼻咽喉头颈外科杂志英文版, 2018, (02) : 110 - 116
  • [36] Gray matter abnormalities in spasmodic dysphonia
    Simonyan, K.
    Ludlow, C. L.
    MOVEMENT DISORDERS, 2008, 23 (01) : S159 - S160
  • [37] BEHAVIORAL-THERAPY FOR SPASMODIC DYSPHONIA
    HEUER, RJ
    JOURNAL OF VOICE, 1992, 6 (04) : 352 - 354
  • [38] Pharyngeal Dystonia Mimicking Spasmodic Dysphonia
    Shi, Lucy L.
    Simpson, C. Blake
    Hapner, Edie R.
    Jinnah, Hyder A.
    Johns, Michael M., III
    JOURNAL OF VOICE, 2018, 32 (02) : 234 - 238
  • [39] MEDICAL EVALUATION OF PATIENTS WITH SPASMODIC DYSPHONIA
    SWENSON, MR
    ZWIRNER, P
    MURRY, T
    WOODSON, GE
    JOURNAL OF VOICE, 1992, 6 (04) : 320 - 324
  • [40] Spasmodic dysphonia: A neural net analysis
    Salvatore, AP
    Cannito, MP
    Gutierrez, GS
    JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY, 1999, 7 (02) : 169 - 174